Asset
VAREGACESTAT
Revenue
No revenue reported in loaded filings.
Clinical trials (5)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06855264 | phase1 | completed | 2025-02-24 | 2025-04-08 | Immunome, Inc. | A Cardiac Liability Study of Varegacestat in Healthy Participants |
| NCT06845852 | phase1 | completed | 2025-02-25 | 2025-03-11 | Immunome, Inc. | A Phase 1 Mass Balance Study of Varegacestat |
| NCT06677996 | phase1 | completed | 2024-11-11 | 2024-12-30 | Immunome, Inc. | A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants |
| NCT04871282 | phase2_3 | active_not_recruiting | 2021-09-01 | 2025-12-03 | Immunome, Inc. | A Study of AL102 in Patients With Progressing Desmoid Tumors |
| NCT06841315 | phase1 | completed | 2025-03-07 | 2025-11-05 | Immunome, Inc. | A Varegacestat Hepatic Impairment Study |
FDA applications (0)
This company has no applications containing this asset.